What Are We Learning From Early-Phase Clinical Trials With Glutamate Targeting Medications for the Treatment of Major Depressive Disorder.
Department of Psychiatry, Yale University, New Haven, Connecticut.
Gerard
G
Sanacora
D000928:Antidepressive Agents; D003865:Major Depressive Disorder; D018698:Glutamic Acid; D006801:Humans
D000928:Antidepressive Agents; D018698:Glutamic Acid